Showing 34,862 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

Harm reduction

Winning Portugal's war on drugs with a policy gamble (Video)

Editor's pick
FRANCE 24
25 November 2021
PrEP programmes & uptake

The Long-Term Prognosis of PrEP (video)

Editor's pick
Contagion Live
25 November 2021
Access to healthcare

How far away is help? Researchers map access to HIV care

Editor's pick
EurekAlert
25 November 2021
Health services & systems

President of Rwanda Urges African Parliaments to Back new African Medicines Agency, the continent's new regulatory authority

Editor's pick
AllAfrica
25 November 2021
Access to healthcare

Nigeria: 1.6m Nigerians On Aids Treatment

Editor's pick
AllAfrica
25 November 2021
Violence

South Africa needs new approaches to end gender-based violence

Editor's pick
Health-e
25 November 2021
Women

Angola: A Day in the Life of a Sexual and Reproductive Health Activist in Angola - How Young People Are Leading Change

Editor's pick
AllAfrica
25 November 2021
Circumcision

Circumcision reducing HIV infections but COVID-19 caused setbacks

Editor's pick
Spotlight
25 November 2021
Discrimination & the law

Australia introduces law that would allow some organisations to ‘discriminate’ based on faith

Editor's pick
The Independent
25 November 2021
UK health services

Leading UK health charities join forces to boost vaccine uptake

Editor's pick
Department of Health and Social Care
25 November 2021
Types of HIV tests

Matthew Hodson explains window periods for HIV testing Video

November 2021
Coronavirus

New COVID-19 Variant With Multiple Concerning Mutations Identified in Southern Africa

Editor's pick
Health Policy Watch
25 November 2021

A second woman may have cured herself of HIV – HIV update, 24 November 2021

November 2021
Discrimination & the law

Sadly, HIV Discrimination Still Happens. Here's What to Do if You Experience It

Editor's pick
TheBody
24 November 2021
Condoms & lubricant

Condoms are a critical part of combination prevention

Editor's pick
UNAIDS
24 November 2021
Government, leadership & policy

Trans People Inadequately Represented in HIV National Strategic Plans

Editor's pick
Contagion Live
24 November 2021
Self-testing & home testing

Chembio Diagnostic Systems Prevails in International Arbitration Against BioSure (UK) Ltd

Editor's pick
GlobeNewswire
24 November 2021
Transgender people

US systematic review finds poor HIV outcomes for trans women and research gap for trans men

News
24 November 2021
Epidemiology

HIV/AIDS still burden of disease in Vietnam

Editor's pick
Saigon Online
23 November 2021
The biology of HIV transmission

HPV Vaccines: The Next HIV Prevention Tool?

Editor's pick
POZ
22 November 2021
New & experimental HIV treatments

Merck pauses 'very important' HIV program after seeing red flag in phase 2 trial of once-weekly combo

Editor's pick
FierceBiotech
22 November 2021
Heterosexual men

One third of men with HIV unaware of their positive status in sub-Saharan Africa

News
22 November 2021
PrEP

PrEP for women in Europe webinars: evaluation form

News
19 November 2021
New & experimental HIV treatments

Merck Provides Update on Phase 2 Clinical Trial of Once-Weekly Investigational Combination of MK-8507 and Islatravir for the Treatment of People Living with HIV-1

Editor's pick
Merck press release
19 November 2021